Switch theme
Sign up to access all valuation multiples
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
2007
6.4K+
LTM Revenue $2.0B
LTM EBITDA $229M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pediatrix has a last 12-month revenue (LTM) of $2.0B and a last 12-month EBITDA of $229M.
In the most recent fiscal year, Pediatrix achieved revenue of $2.0B and an EBITDA of -$28.4M.
Pediatrix expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pediatrix valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Profit | $222M | XXX | $454M | XXX | XXX | XXX |
| Gross Margin | 11% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $229M | XXX | -$28.4M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | -1% | XXX | XXX | XXX |
| EBIT | $185M | XXX | $184M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | -$5.0M | XXX | -$99.1M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | -5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $382M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Pediatrix's stock price is $14.
Pediatrix has current market cap of $1.2B, and EV of $1.7B.
See Pediatrix trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.2B | XXX | XXX | XXX | XXX | $1.57 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Pediatrix has market cap of $1.2B and EV of $1.7B.
Pediatrix's trades at 0.8x EV/Revenue multiple, and -58.2x EV/EBITDA.
Equity research analysts estimate Pediatrix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pediatrix has a P/E ratio of -245.4x.
See valuation multiples for Pediatrix and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 7.2x | XXX | -58.2x | XXX | XXX | XXX |
| EV/EBIT | 8.9x | XXX | 9.0x | XXX | XXX | XXX |
| EV/Gross Profit | 7.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -245.4x | XXX | -12.3x | XXX | XXX | XXX |
| EV/FCF | 12.0x | XXX | 8.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPediatrix's last 12 month revenue growth is -3%
Pediatrix's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $42K for the same period.
Pediatrix's rule of 40 is -1% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pediatrix's rule of X is 4% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pediatrix and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | -2% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | -1% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 180% | XXX | XXX | XXX |
| Rule of 40 | -1% | XXX | -4% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 4% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $42K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pediatrix acquired XXX companies to date.
Last acquisition by Pediatrix was XXXXXXXX, XXXXX XXXXX XXXXXX . Pediatrix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Pediatrix founded? | Pediatrix was founded in 2007. |
| Where is Pediatrix headquartered? | Pediatrix is headquartered in United States of America. |
| How many employees does Pediatrix have? | As of today, Pediatrix has 6.4K+ employees. |
| Who is the CEO of Pediatrix? | Pediatrix's CEO is Mr. Mark S. Ordan. |
| Is Pediatrix publicy listed? | Yes, Pediatrix is a public company listed on NYS. |
| What is the stock symbol of Pediatrix? | Pediatrix trades under MD ticker. |
| When did Pediatrix go public? | Pediatrix went public in 1959. |
| Who are competitors of Pediatrix? | Similar companies to Pediatrix include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Pediatrix? | Pediatrix's current market cap is $1.2B |
| What is the current revenue of Pediatrix? | Pediatrix's last 12 months revenue is $2.0B. |
| What is the current revenue growth of Pediatrix? | Pediatrix revenue growth (NTM/LTM) is -3%. |
| What is the current EV/Revenue multiple of Pediatrix? | Current revenue multiple of Pediatrix is 0.8x. |
| Is Pediatrix profitable? | Yes, Pediatrix is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pediatrix? | Pediatrix's last 12 months EBITDA is $229M. |
| What is Pediatrix's EBITDA margin? | Pediatrix's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Pediatrix? | Current EBITDA multiple of Pediatrix is 7.2x. |
| What is the current FCF of Pediatrix? | Pediatrix's last 12 months FCF is $137M. |
| What is Pediatrix's FCF margin? | Pediatrix's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Pediatrix? | Current FCF multiple of Pediatrix is 12.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
